Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $11.2 Million - $14.3 Million
-88,770 Reduced 83.34%
17,746 $2.37 Million
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $12 Million - $14.3 Million
84,786 Added 390.18%
106,516 $16.6 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $2.82 Million - $3.49 Million
21,730 New
21,730 $3.38 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $966,060 - $1.08 Million
-6,000 Closed
0 $0
Q2 2018

Jul 19, 2018

BUY
$146.33 - $183.18 $877,980 - $1.1 Million
6,000 New
6,000 $1.03 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.